Home・Akcijų sąrašas・Erasca Inc

Erasca Inc

Uždarymo kaina

19.52 0.46

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

18.82

Max

19.78

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-154M -183M
Pelnas, tenkantis vienai akcijai	-0.6
Darbuotojai	103
EBITDA	-151M -183M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+15.58% upside

Dividendai
By Acuity
Kitas uždarbis	2026-08-10

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	3.3B 6.5B
Ankstesnė atidarymo kaina	19.06
Ankstesnė uždarymo kaina	19.52

Erasca Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-22 23:56; UTC

AAR Corp shares are higher in after-market hours, reflecting earlier fluctuations. The stock remains below its 20-day moving average and near its one-month trading range.

2026-07-22 23:56; UTC

Correlated Moves

News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

2026-07-22 23:56; UTC

HCA Healthcare Inc shares are trading higher in after-market hours. Broader market sentiment is influenced by geopolitical tensions and rising crude oil prices.

2026-07-22 23:56; UTC

Correlated Moves

Lyft Inc shares are higher in after-market trading, showing a slight increase since Wednesday's close amid broader market dynamics and fluctuations in the ride-sharing sector.

2026-07-22 23:56; UTC

Correlated Moves

Costco Wholesale shares are lower in after-market hours amid ongoing geopolitical tensions and rising crude oil prices affecting market sentiment.

2026-07-22 23:56; UTC

ETF Constituents

The iShares Biotechnology ETF is trading higher in after-market hours, supported by gains from Medpace Holdings and other key holdings.

2026-07-22 23:56; UTC

Correlated Moves

Element Solutions Inc shares are higher in after-market trading, reflecting a modest gain. Similar trends were noted in correlated asset ITT Inc.

2026-07-22 23:56; UTC

Correlated Moves

Coeur Mining Inc shares are lower in after-market hours, reflecting a decline linked to a slight drop in silver prices.

2026-07-22 23:56; UTC

Badger Meter Inc shares are higher in after-market trading, recovering from earlier volatility without any specific news to explain the movement.

2026-07-22 23:56; UTC

Correlated Moves

Rambus Inc shares are higher in after-market trading, reflecting positive movement since Wednesday's close, alongside gains in MACOM Technology Solutions. Geopolitical tensions persist.

2026-07-22 23:56; UTC

Exelon shares are lower in after-market trading, reflecting stable performance within a one-month trading range. No specific news was identified.

2026-07-22 23:56; UTC

American Superconductor shares are lower in after-market trading, retracing from earlier gains and remaining below their 20-day moving average.

2026-07-22 23:56; UTC

NextDecade Corp. shares are lower in after-market hours amid geopolitical tensions and rising oil prices, reflecting routine fluctuations without specific company news.

2026-07-22 23:56; UTC

Comfort Systems USA Inc shares are lower in after-market trading, following a trend of higher closes. No specific news was identified for this movement.

2026-07-22 23:56; UTC

MasTec Inc. shares are modestly higher in after-market hours, with no specific company news identified. Broader market sentiment may be influenced by geopolitical tensions.

2026-07-22 23:56; UTC

Correlated Moves

Fortuna Silver Mines Inc. is trading lower in after-market hours, reflecting broader declines in the precious metals market amid ongoing geopolitical tensions.

2026-07-22 23:56; UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

2026-07-22 23:56; UTC

Intellia Therapeutics Inc shares are higher in after-market trading, though they remain below their 20-day moving average and near the lower end of their one-month range.

2026-07-22 23:56; UTC

ETF Constituents

iShares China Large-Cap ETF declines after market close, impacted by JD's negative return. The ETF remains above its 20-day moving average.

2026-07-22 23:56; UTC

Newmont Corporation shares are higher in after-market hours, reflecting a modest increase since Wednesday's close, with no specific news identified for the movement.

2026-07-22 23:56; UTC

Under Armour Inc shares are slightly higher in after-market hours, maintaining a position near the upper end of their one-month range.

2026-07-22 23:52; UTC

Lumentum Holdings Inc shares are higher in after-market trading, significantly above Wednesday's close and near the upper end of its one-month trading range.

2026-07-22 23:51; UTC

Blue Owl Capital Corp shares are higher in after-market trading. No specific news was identified to explain this movement amid cautious broader market sentiment.

2026-07-22 23:51; UTC

Upwork Inc. shares are lower during after-market hours amid broader market declines. Rising crude oil prices and geopolitical tensions are contributing to negative sentiment.

2026-07-22 23:51; UTC

MACOM Technology Solutions is higher in after-market trading, reflecting positive sentiment despite broader market concerns over rising crude oil prices and geopolitical tensions.

2026-07-22 23:51; UTC

Pinnacle West Capital Corp shares are lower in after-market trading, continuing weak sentiment from earlier. Broader market dynamics may be influencing cautious investor sentiment.

2026-07-22 23:51; UTC

HP Inc. shares are little changed in after-market trading. The broader market is lower amid rising crude oil prices and uncertainty over the Fed's interest rate decision.

2026-07-22 23:51; UTC

Ambarella Inc shares are higher in after-market trading, recovering from earlier fluctuations. Broader market sentiment remains cautious amid rising crude oil prices.

2026-07-22 23:51; UTC

Correlated Moves

Photronics Inc shares are higher in after-market trading, supported by a positive trend and correlations with MACOM Technology Solutions Holdings Inc.

2026-07-22 23:51; UTC

PDD Holdings Inc shares are higher in after-market trading, despite no specific news driving the price movement. The stock remains above its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Erasca Inc Prognozė

Kainos tikslas

By TipRanks

15.58% į viršų

12 mėnesių prognozė

Vidutinis 22.4 USD 15.58%

Aukščiausias 30 USD

Žemiausias 18 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Erasca Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

10 ratings

Pirkti

Laikyti

Parduoti

Remiantis 10 analitikų, pateikusių Erasca Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.